Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors

MLA

Yu Chien Kao, et al. “Toward a Unifying Entity That Encompasses Most, but Perhaps Not All, Inflammatory Leiomyosarcomas and Histiocyte-Rich Rhabdomyoblastic Tumors.” Modern Pathology, vol. 34, July 2021, pp. 1434–38. EBSCOhost, https://doi.org/10.1038/s41379-021-00797-8.

APA

Yu Chien Kao, Yung Chuan Chung, Hsuan-Ying Huang, Jen-Chieh Lee, & Wan Shan Li. (2021). Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors. Modern Pathology, 34, 1434–1438. https://doi.org/10.1038/s41379-021-00797-8

Chicago

Yu Chien Kao, Yung Chuan Chung, Hsuan-Ying Huang, Jen-Chieh Lee, and Wan Shan Li. 2021. “Toward a Unifying Entity That Encompasses Most, but Perhaps Not All, Inflammatory Leiomyosarcomas and Histiocyte-Rich Rhabdomyoblastic Tumors.” Modern Pathology 34 (July): 1434–38. doi:10.1038/s41379-021-00797-8.